Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2025-12-24 @ 4:50 PM
NCT ID:
NCT05334550
Eligibility Criteria:
Inclusion Criteria:
* Extreme premature baby (gestationl age 23\~28 weeks)
* Corrected age under one month at the time of enroll of this study
* Children of those who voluntarily decided to participate after hearing detailed explanations about this study and gave their written consent.
* Children whose parents are Korean
Exclusion Criteria:
* Congenital anomalies in the central nervous system
* Hereditary diseases
* Chromosomal abnormalities (Down syndrome, etc.)
* Stage 3 or more intraventricular hemorrhage
* If surgery was performed for hydrocephalus
* Leukomalacia confirmed by ultrasound examination (not applicable to increase in white matter shading)
* Neonatal asphyxia
* Other central nervous system diseases
* If taking medications for convulsions or epilepsy
* Metabolic disease
* In the case of premature infants undergoing surgery for retinal disease
* Hearing loss
* In case of surgery due to complex congenital anomaly or planned operation (not excluded if surgery is not required)
* In case of oxygen dependence due to lung disease in premature infants
* Musculoskeletal disorders (hip dislocation, polyarthrosis, etc.)
* Neuromuscular disease, etc.
* Those whose family has social problems
* Those whose parents cannot participate in this study
* Those who have other serious complications that cannot proceed with the study
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT05334550
Study Brief:
Protocol Section:
NCT05334550